News

Truenat is today fulfilling goal of being a multi-disease platform: Chandrasekhar Nair, Molbio Diagnostics

Shardul Nautiyal, Financial Express Health care, October 26, 2021

Truenat was validated extensively by ICMR and FIND for Indian and WHO approvals for sensitive and rapid detection of MDR-TB

Molbio Diagnostics receives DCGI nod for Scrub Typhus test

ET Health World; October 11, 2021, October 11, 2021

Truenat by Molbio is a point of care Real-Time PCR platform that had earlier been approved to detect numerous infectious diseases like COVID-19, Tuberculosis, H1N1, Dengue, Hepatitis amongst others

Speeding up medical intervention

The Navhind Time Desk, October 03, 2021

NT NETWORK speaks with founder-director and chief executive officer, Molbio Diagnostics, Sriram Natarajan to find out about Truenat, human diagnostics, trends in healthcare, and more

Diagnostics Sector In India: Challenges And Opportunities Presented By COVID-19 Pandemic

Longjam Dineshwori, The Health Site, September 21,2021, September 21, 2021

It underlined the need for simple point-of-care solutions that can be used by anyone, anywhere with minimal investments. Goa-based Molbio Diagnostics' Truenat platform, a point-of-care molecular diagnostics system, has been playing a significant role in the fight against COVID-19. The single platform can test 30+ diseases and share the results in less than an hour

Eyeing to be a major player in the global molecular diagnostics market

Prathiba Raju, ET Health World, September 15, 2021, September 15, 2021

Truenat RT- PCR is expected to become more of a routine clinical diagnostics tool not only for COVID, but for a wide range of infectious diseases in the near future

Molbio Diagnostics gets DCGI nod for Nipah virus testing

PTI, The Economic Times, September 08, 2021

Molbio Diagnostics on Wednesday said its platform Truenat has received emergency use authorisation from DCGI for Nipah virus testing. Testing for Nipah virus can now be performed rapidly on Truenat, a real-time PCR platform, on demand, the Goa-based firm 

Truenat test kit gets DCGI approval for Nipah diagnosis

Biospectrum, September 08, 2021

This is the first kit in India to receive regulatory approval to conduct tests for Nipah. Truenat, an innovative point of care Real-Time PCR platform manufactured by Goa-based Molbio Diagnostics, has received Emergency Use Authorization by the Drugs Controller General of India (DCGI) for their Nipah test.

TrueNat test kit first in India to get ‘emergency use’ approval for Nipah virus diagnosis

MOHANA BASU, The Print, September 08, 2021

Goa-based Molbio Diagnostics has received emergency use authorisation by the Drugs Controller General of India (DCGI) for their Nipah test kit, making it the first in India to receive regulatory approval to conduct tests for the zoonotic disease.

Research Publication: TRUENAT: A Rapid RT-PCR Test for the detection of SARS CoV2 infection at a tertiary care hospital in J&K

Sharma et al., 2021, August 17, 2021

The present study was conducted at a tertiary care center, approved by Indian Council of Medical Research for COVID-19 TrueNat testing from July 2020 to June 2021

Revolutionising molecular diagnostic testing

The Navhind Time Desk, August 09, 2021

Verna based Molbio Diagnostics Pvt Ltd, is looking for growth in its core area of molecular diagnostics